Schizophrenia and 22q11.2 deletion syndrome.
paper
Cited
Public
Unavailable
- Authors
- Bassett, Anne S; Chow, Eva W C
- Year
- 2008
- Journal
- Current psychiatry reports
- PMID
- 18474208
- DOI
- 10.1007/s11920-008-0026-1
- PMCID
- PMC3129332
22q11.2 deletion syndrome (22qDS) is a genetic syndrome associated with a chromosome 22q11.2 deletion and variable phenotypic expression that commonly includes schizophrenia. Approximately 1% of patients with schizophrenia have 22qDS. The schizophrenia in 22qDS appears broadly similar to that found in the general population with respect to core signs and symptoms, treatment response, neurocognitive profile, and MRI brain anomalies. However, individuals with a 22qDS form of schizophrenia typically have distinguishable physical features, have a lower IQ, and may differ in auxiliary clinical features. IQ, length of 22q11.2 deletions, and COMT functional allele do not appear to be major risk factors for schizophrenia in 22qDS. Ascertainment biases and small sample sizes are limitations of most studies. Larger studies over the lifespan and continuing education about this underrecognized condition are needed. 22qDS-schizophrenia is an important genetic subtype and a valuable model of neurodevelopmental mechanisms involved in the pathogenesis of schizophrenia.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review. | Arican I et al. | β | 2026 | β |
| An exploratory fetal MRI study examining the impact of 22q11.2 microdeletion syndrome on early brain growth. | Cromb D et al. | β | 2025 | β |
| Copy Number Variant Architecture of Child Psychopathology and Cognitive Development in the ABCD Study. | Sha Z et al. | β | 2025 | β |
| Impact of genomic sequencing information on physicians' treatment recommendations for children with congenital heart disease. | Char DS et al. | β | 2025 | β |
| Neuronal Synaptic Communication and Mitochondrial Energetics in Human Health and Disease. | Glausier JR | β | 2025 | β |
| New-Onset Mania With Psychotic Features in a Patient With DiGeorge Syndrome, HIV, Syphilis, and Pulmonary Hypertension. | Chen G et al. | β | 2025 | β |
| Presence, Severity, and Functional Associations of Incomplete Hippocampal Inversion in 22q11.2 Deletion Syndrome. | Roalf D et al. | β | 2025 | β |
| Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia. | Accinni T et al. | β | 2025 | β |
| Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models. | Perrottelli A et al. | β | 2024 | β |
| Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. | Clementz BA et al. | β | 2024 | β |
| Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders. | Roalf DR et al. | β | 2024 | β |
| Parkinson's disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes. | Karunakaran KB et al. | β | 2024 | β |
| Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study. | Supekar K et al. | β | 2024 | β |
| Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome. | Zafarullah M et al. | β | 2024 | β |
| Altered corollary discharge signaling in the auditory cortex of a mouse model of schizophrenia predisposition. | Rummell BP et al. | β | 2023 | β |
| Associations between acute and chronic lifetime stressors and psychosis-risk symptoms in individuals with 22q11.2 copy number variants. | Modasi J et al. | β | 2023 | β |
| Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease. | Bowen ER et al. | β | 2023 | β |
| Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome. | Smyk M et al. | β | 2023 | β |
| Copy Number Variations in Neuropsychiatric Disorders. | BΓΌki G et al. | β | 2023 | β |
| Epigenetic Targets in Schizophrenia Development and Therapy. | Wawrzczak-BargieΕa A et al. | β | 2023 | β |
| Genome-wide copy number variant screening of Saudi schizophrenia patients reveals larger deletions in cases versus controls. | Abumadini MS et al. | β | 2023 | β |
| Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction. | Forsyth JK et al. | β | 2023 | β |
| A framework for integration of dimensional and diagnostic approaches to the diagnosis of schizophrenia. | Gordon JA et al. | β | 2022 | β |
| Agency Deficits in a Human Genetic Model of Schizophrenia: Insights From 22q11DS Patients. | Salomon R et al. | β | 2022 | β |
| An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and schizophrenia. | Morris E et al. | β | 2022 | β |
| Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. | Lin P et al. | β | 2022 | β |
| Environmental Influences on the Relation between the 22q11.2 Deletion Syndrome and Mental Health: A Literature Review. | Snihirova Y et al. | β | 2022 | β |
| Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome. | Tepper Γ et al. | β | 2022 | β |
| Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls. | Jalbrzikowski M et al. | β | 2022 | β |
| Neurological manifestation of 22q11.2 deletion syndrome. | Bayat M et al. | β | 2022 | β |
| Schizophrenia: a Narrative Review of Etiological and Diagnostic Issues. | Oskolkova S | β | 2022 | β |
| Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome. | Ying S et al. | β | 2022 | β |
| The 14-3-3 Protein Family and Schizophrenia. | Navarrete M et al. | β | 2022 | β |
| The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. | Millard SJ et al. | β | 2022 | β |
| A Case for Thalamic Mechanisms of Schizophrenia: Perspective From Modeling 22q11.2 Deletion Syndrome. | Jiang Y et al. | β | 2021 | β |
| Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression. | Ni P et al. | β | 2021 | β |
| Atypical attentional filtering of visual information in youth with chromosome 22q11.2 deletion syndrome as indexed by event-related potentials. | Linton SR et al. | β | 2021 | β |
| Differential resting-state patterns across networks are spatially associated with Comt and Trmt2a gene expression patterns in a mouse model of 22q11.2 deletion. | Gass N et al. | β | 2021 | β |
| Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls. | McCutcheon RA et al. | β | 2021 | β |
| Ethical issues in genomics research on neurodevelopmental disorders: a critical interpretive review. | Mezinska S et al. | β | 2021 | β |
| Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. | Maini K et al. | β | 2021 | β |
| MicroRNAs in the Onset of Schizophrenia. | Thomas KT et al. | β | 2021 | β |
| Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome. | Fiksinski AM et al. | β | 2021 | β |
| Translatable pathways classification (TransPath-C) for inferring processes germane to human biology from animal studies data: example application in neurobiology. | Carroll MJ et al. | β | 2021 | β |
| 22q11.2 deletion syndrome and schizophrenia. | Qin X et al. | β | 2020 | β |
| A Role for SERCA Pumps in the Neurobiology of Neuropsychiatric and Neurodegenerative Disorders. | Britzolaki A et al. | β | 2020 | β |
| Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome. | Francisco AA et al. | β | 2020 | β |
| Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin. | Hanger B et al. | β | 2020 | β |
| Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size. | Sun D et al. | β | 2020 | β |
| Neural and behavioral measures suggest that cognitive and affective functioning interactions mediate risk for psychosis-proneness symptoms in youth with chromosome 22q11.2 deletion syndrome. | Linton SR et al. | β | 2020 | β |
| Neuronal defects in a human cellular model of 22q11.2 deletion syndrome. | Khan TA et al. | β | 2020 | β |
| Post-translational protein modifications in schizophrenia. | Mueller TM et al. | β | 2020 | β |
| Schizophrenia-An Overview. | McCutcheon RA et al. | β | 2020 | β |
| Various Psychiatric Manifestation in DiGeorge Syndrome (22q11.2 Deletion Syndrome): A Case Report. | Kim G et al. | β | 2020 | β |
| An Overview of Animal Models Related to Schizophrenia. | Winship IR et al. | β | 2019 | β |
| Atypical chromosome 22q11.2 deletions are complex rearrangements and have different mechanistic origins. | Vervoort L et al. | β | 2019 | β |
| Dissociable Disruptions in Thalamic and Hippocampal Resting-State Functional Connectivity in Youth with 22q11.2 Deletions. | Schleifer C et al. | β | 2019 | β |
| Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome. | Dantas AG et al. | β | 2019 | β |
| Exploration, Inference, and Prediction in Neuroscience and Biomedicine. | Bzdok D et al. | β | 2019 | β |
| How to approach a patient with parkinsonism - red flags for atypical parkinsonism. | Mulroy E et al. | β | 2019 | β |
| Seeing Eye to Eye With Threat: Atypical Threat Bias in Children With 22q11.2 Deletion Syndrome. | Popa AM et al. | β | 2019 | β |
| Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior. | Gokhale A et al. | β | 2019 | β |
| Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study. | Kates WR et al. | β | 2019 | β |
| Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells. | Hoffmann A et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson's Disease. | Gambardella S et al. | β | 2018 | β |
| Numerical Processing Impairment in 22q11.2 (LCR22-4 to LCR22-5) Microdeletion: A Cognitive-Neuropsychological Case Study. | Oliveira LFS et al. | β | 2018 | β |
| Periventricular nodular heterotopia in 22q11.2 deletion and frontal lobe migration. | Rezazadeh A et al. | β | 2018 | β |
| Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences. | Bogdan R et al. | β | 2018 | β |
| Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior | Gokhale A et al. | β | 2018 | β |
| The dynamics of disordered dialogue: Prefrontal, hippocampal and thalamic miscommunication underlying working memory deficits in schizophrenia. | Kupferschmidt DA et al. | β | 2018 | β |
| The location discrimination reversal task in mice is sensitive to deficits in performance caused by aging, pharmacological and other challenges. | Graf R et al. | β | 2018 | β |
| The SERCA2: A Gatekeeper of Neuronal Calcium Homeostasis in the Brain. | Britzolaki A et al. | β | 2018 | β |
| Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. | Boot E et al. | β | 2018 | β |
| Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome. | Fiksinski AM et al. | β | 2018 | β |
| White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline. | Nuninga JO et al. | β | 2018 | β |
| A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia. | Fischer EK et al. | β | 2017 | β |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | β | 2017 | β |
| Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA. | Advani HV et al. | β | 2017 | β |
| Critical region within 22q11.2 linked to higher rate of autism spectrum disorder. | Clements CC et al. | β | 2017 | β |
| Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis. | Radoeva PD et al. | β | 2017 | β |
| Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis. | Radoeva PD et al. | β | 2017 | β |
| Mapping 22q11.2 Gene Dosage Effects on Brain Morphometry. | Lin A et al. | β | 2017 | β |
| Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting. | Bassett AS et al. | β | 2017 | β |
| Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment. | Dufournet B et al. | β | 2017 | β |
| Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells. | Prytkova I et al. | β | 2017 | β |
| Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. | Weisman O et al. | β | 2017 | β |
| The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths. | Tang SX et al. | β | 2017 | β |
| The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia. | Howes OD et al. | β | 2017 | β |
| Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders. | Rutkowski TP et al. | β | 2017 | β |
| A catalog of hemizygous variation in 127 22q11 deletion patients. | Hestand MS et al. | β | 2016 | β |
| Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data. | Mok KY et al. | β | 2016 | β |
| [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis]. | Kaltenboeck A et al. | β | 2016 | β |
| Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion. | Lin M et al. | β | 2016 | β |
| Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts. | Yi JJ et al. | β | 2016 | β |
| [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia]. | Huertas-RodrΓguez CK et al. | β | 2015 | β |
| Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. | Guna A et al. | β | 2015 | β |
| Congenital heart disease in the older adult: a scientific statement from the American Heart Association. | Bhatt AB et al. | β | 2015 | β |
| Genetics in child and adolescent psychiatry: methodological advances and conceptual issues. | Hohmann S et al. | β | 2015 | β |
| MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. | Zhao D et al. | β | 2015 | β |
| Olanzapine-induced DNA methylation in the hippocampus and cerebellum in genes mapped to human 22q11 and implicated in schizophrenia. | Melka MG et al. | β | 2015 | β |
| Practical guidelines for managing adults with 22q11.2 deletion syndrome. | Fung WL et al. | β | 2015 | β |
| Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome. | Chan C et al. | β | 2015 | β |
| Response to clozapine in a clinically identifiable subtype of schizophrenia. | Butcher NJ et al. | β | 2015 | β |
| The Danish 22q11 research initiative. | Schmock H et al. | β | 2015 | β |
| A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. | Besseau-Ayasse J et al. | β | 2014 | β |
| Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes. | Radoeva PD et al. | β | 2014 | β |
| Distal 10q monosomy: new evidence for a neurobehavioral condition? | PlaisanciΓ© J et al. | β | 2014 | β |
| High rate of disease-related copy number variations in childhood onset schizophrenia. | Ahn K et al. | β | 2014 | β |
| Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia. | Forstner AJ et al. | β | 2014 | β |
| Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons. | Belinsky GS et al. | β | 2014 | β |
| Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. | Tang SX et al. | β | 2014 | β |
| Risk genes for schizophrenia: translational opportunities for drug discovery. | Winchester CL et al. | β | 2014 | β |
| 22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis. | Squarcione C et al. | β | 2013 | β |
| Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. | Chana G et al. | β | 2013 | β |
| Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. | Hiroi N et al. | β | 2013 | β |
| Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. | Monteiro FP et al. | β | 2013 | β |
| Developmental mechanisms in the prodrome to psychosis. | Walker EF et al. | β | 2013 | β |
| Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. | Vorstman JA et al. | β | 2013 | β |
| MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review. | Forstner AJ et al. | β | 2013 | β |
| New findings in the genetics of schizophrenia. | Hosak L | β | 2013 | β |
| Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. | Lionel AC et al. | β | 2013 | β |
| 22q11.2 deletion syndrome: attitudes towards disclosing the risk of psychiatric illness. | Martin N et al. | β | 2012 | β |
| Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. | Costain G et al. | β | 2012 | β |
| Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. | Costain G et al. | β | 2012 | β |
| Comparing the neural bases of self-referential processing in typically developing and 22q11.2 adolescents. | Schneider M et al. | β | 2012 | β |
| Detection and characterization of copy number variation in autism spectrum disorder. | Marshall CR et al. | β | 2012 | β |
| Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. | Need AC et al. | β | 2012 | β |
| Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia. | Kumarasinghe N et al. | β | 2012 | β |
| Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. | Grozeva D et al. | β | 2012 | β |
| Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder. | Graw SL et al. | β | 2012 | β |
| miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome. | Brzustowicz LM et al. | β | 2012 | β |
| Mouse Models of 22q11.2-Associated Autism Spectrum Disorder. | Hiroi N et al. | β | 2012 | β |
| Phenotypic heterogeneity in a family with a small atypical microduplication of chromosome 22q11.2 involving TBX1. | Weisfeld-Adams JD et al. | β | 2012 | β |
| Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome. | Schneider M et al. | β | 2012 | β |
| Assessment of 22q11.2 copy number variations in a sample of Brazilian schizophrenia patients. | Christofolini DM et al. | β | 2011 | β |
| Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. | Chow EW et al. | β | 2011 | β |
| Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample. | Jitoku D et al. | β | 2011 | β |
| Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. | Philip N et al. | β | 2011 | β |
| Commentary: Anxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series. | Bassett AS | β | 2011 | β |
| Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. | Levinson DF et al. | β | 2011 | β |
| Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. | Pedrosa E et al. | β | 2011 | β |
| Genetic counseling in the adult with congenital heart disease: what is the role? | Burchill L et al. | β | 2011 | β |
| Parental origin, DNA structure, and the schizophrenia spectrum. | Bassett AS | β | 2011 | β |
| Practical guidelines for managing patients with 22q11.2 deletion syndrome. | Bassett AS et al. | β | 2011 | β |
| 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. | van Engelen K et al. | β | 2010 | β |
| Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. | Bassett AS et al. | β | 2010 | β |
| Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. | Bassett AS et al. | β | 2010 | β |
| Genome-wide scan of copy number variation in late-onset Alzheimer's disease. | Heinzen EL et al. | β | 2010 | β |
| Newborn screening programs: should 22q11 deletion syndrome be added? | Bales AM et al. | β | 2010 | β |
| Prevention of schizophrenia. | Tsuang MT et al. | β | 2010 | β |
| A genome-wide investigation of SNPs and CNVs in schizophrenia. | Need AC et al. | β | 2009 | β |
| A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. | Need AC et al. | β | 2009 | β |
| A new wave in the genetics of psychiatric disorders: the copy number variant tsunami. | Joober R et al. | β | 2009 | β |
| Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. | Vorstman JA et al. | β | 2009 | β |
| Genomic sister-disorders of neurodevelopment: an evolutionary approach. | Crespi B et al. | β | 2009 | β |
| Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome). | Tan GM et al. | β | 2009 | β |
| Premature death in adults with 22q11.2 deletion syndrome. | Bassett AS et al. | β | 2009 | β |
| Psychiatric phenotypes associated with neurogenetic disorders. | Feinstein C et al. | β | 2009 | β |
| Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome). | Jolin EM et al. | β | 2009 | β |
| Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. | Alaerts M et al. | β | 2009 | β |
| Tetralogy of Fallot. | Apitz C et al. | β | 2009 | β |
| The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome. | Zaleski C et al. | β | 2009 | β |
| Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. | Bassett AS et al. | β | 2008 | β |
| Copy variations in schizophrenia and bipolar disorder. | Lachman HM | β | 2008 | β |
| Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. | Budel S et al. | β | 2008 | β |
| Genomic structural variation and schizophrenia. | Mulle JG | β | 2008 | β |
| Phenotype matters: the case for careful characterization of relevant traits. | Brzustowicz LM et al. | β | 2008 | β |